BeOne Medicines (ONC) EBIT Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 12.69% |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 75.16% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -347.04% |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 80.62% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 8.65% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 1.27% |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 1,386.07% |
| 10 | BeOne Medicines | - | - | 1.35 Bn | 2,150.96% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,150.96% |
| Dec 31, 2025 | 332.97% |
| Sep 30, 2025 | 235.63% |
| Jun 30, 2025 | 182.01% |
| Mar 31, 2025 | 104.25% |
| Dec 31, 2024 | 79.31% |
| Sep 30, 2024 | 10.23% |
| Jun 30, 2024 | 66.38% |
| Mar 31, 2024 | 29.60% |
| Dec 31, 2023 | 18.10% |
| Sep 30, 2023 | 69.44% |
| Jun 30, 2023 | 27.47% |
| Mar 31, 2023 | 16.25% |
| Dec 31, 2022 | -345.92% |
| Sep 30, 2022 | 5.18% |
| Jun 30, 2022 | 7.46% |
| Mar 31, 2022 | -731.76% |
| Dec 31, 2021 | 139.30% |
| Sep 30, 2021 | -5.04% |
| Jun 30, 2021 | -32.31% |
| Mar 31, 2021 | 118.77% |
| Dec 31, 2020 | -24.97% |
| Sep 30, 2020 | -40.95% |
| Jun 30, 2020 | -318.11% |
| Mar 31, 2020 | -115.11% |
| Dec 31, 2019 | -38.19% |
| Sep 30, 2019 | -106.66% |
| Jun 30, 2019 | 47.36% |
| Mar 31, 2019 | -56.81% |
| Dec 31, 2018 | -170.53% |
| Sep 30, 2018 | -231.50% |
| Jun 30, 2018 | -181.01% |
| Mar 31, 2018 | -114.99% |
| Dec 31, 2017 | -178.50% |
| Sep 30, 2017 | 429.92% |
| Jun 30, 2017 | -135.59% |
| Mar 31, 2017 | -153.48% |
| Dec 31, 2016 | -41.30% |
| Sep 30, 2016 | -148.91% |
| Jun 30, 2016 | -275.14% |
| Mar 31, 2016 | -107.24% |